ArticleFrontiers in public health2026
The impact of DIP payment reform on hospitalization costs and equity in type 2 diabetes mellitus patients: evidence from a pilot city in Central China.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In order to regulate the surging medical spending, the Chinese government conducted a reform of medical insurance payment directed to regional global budgets and Diagnosis-Intervention Packet (DIP) system. Methods: An interrupted time series analysis was conducted using monthly medical insurance claims data from 45,900 T2DM inpatients in S City, China between January 2020 and December 2023, comparing outcomes before and after the January 2021 DIP reform implementation across insurance types (UEBMI vs. URRBMI) and hospital types (TCM vs. general hospitals). Results: The DIP reform significantly reduced total hospitalization costs and length of stay overall, but divergently affected out-of-pocket ratios-decreasing them for UEBMI enrollees while significantly increasing them for URRBMI patients and TCM hospital patients-indicating worsened financial equity for vulnerable subgroups despite improved cost. Conclusion: While the DIP payment reform effectively reduced hospitalization costs and length of stay for T2DM patients, it simultaneously exacerbated out-of-pocket inequities across insurance schemes and hospital types, indicating that future payment policies must integrate cost containment with health equity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.